Palisade Bio Announces 1-for-15 Reverse Stock SplitGlobe Newswire • about 1 month ago
Carlsbad,CA, April 03, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI), ( Palisade , Palisade Bio or the Company ), a biopharmaceutical company focused on developing and...
Share to Feed
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Theres a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Inventiva (IVA Research Report) and Palisade Bio...
Rapid advancement of PALI-2108 towards Phase 1 clinical study for the treatment of moderate-to-severe ulcerative colitis; On track to commence Phase 1 before year end Formation of Clinical...
Carlsbad,CA, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) ( Palisade or the Company ), a biopharmaceutical company focused on developing novel therapeutics for...
Palisade Bio (PALI) has released an update. Dive into the latest buzz from the financial world as a renowned company unveils a corporate update tha...
Company announces strategic streamlining of Board to align with the current state of clinical development and corporate vision Advancement of PALI-2108 for the treatment of moderate-to-severe...
Carlsbad,CA, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) ( Palisade or the Company ), a biopharmaceutical company focused on developing novel therapeutics for...
Palisade Bio, Inc.
Bruce Sands MD, MS
Palisade Bio, Inc.
Florian Rieder, MD
Bruce Sands, MD, MS., Dr. Burrill B. Crohn Professor of Medicine, Icahn School...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...